{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/clinical-trial-registration-and-updates-anzctr”
},
“@id”: “https://www.clinicalstudies.in/clinical-trial-registration-and-updates-anzctr”,
“headline”: “SOP for Clinical Trial Registration and Updates in ANZCTR”,
“name”: “SOP for Clinical Trial Registration and Updates in ANZCTR”,
“description”: “Comprehensive SOP outlining sponsor and investigator responsibilities for registering clinical trials in ANZCTR, maintaining updates, and ensuring compliance with HDEC, Medsafe, WHO, and ICMJE requirements.”,
“keywords”: “Trial registration SOP New Zealand, SOP for ANZCTR registration NZ, SOP for clinical trial registry submissions NZ, SOP for Medsafe registry compliance, SOP for HDEC registry submissions, SOP for investigator responsibilities trial registration NZ, SOP for sponsor obligations NZ registry, SOP for CRO registry support NZ, SOP for registry update timelines NZ, SOP for protocol registration NZ, SOP for results posting NZ, SOP for transparency compliance NZ, SOP for registry audits NZ, SOP for inspection readiness registry NZ, SOP for trial subject protection NZ registry, SOP for WHO registry requirements NZ, SOP for ICMJE compliance trial registration NZ, SOP for ethics approval and registry NZ,
“articleSection”: “Standard Operating Procedure”,
“datePublished”: “2025-08-28”,
“dateModified”: “2025-08-28”,
“author”: { “@type”: “Organization”, “name”: “Clinicalstudies.in” },
“publisher”: {
“@type”: “Organization”,
“name”: “Clinicalstudies.in”,
“logo”: { “@type”: “ImageObject”, “url”: “https://www.clinicalstudies.in/logo.png” }
}
}
Published on 23/12/2025
Clinical Trial Registration and Updates in ANZCTR SOP
| Department | Clinical Research |
|---|---|
| SOP No. | CS/NZ-REG/205/2025 |
| Supersedes | N.A. |
| Page No. | 1 of 25 |
| Issue Date | 28/08/2025 |
| Effective Date | 05/09/2025 |
| Review Date | 05/09/2027 |
Purpose
The purpose of this SOP is to define processes for clinical trial registration and updates in the Australia New Zealand Clinical Trials Registry (ANZCTR). This ensures transparency, ethical compliance, and alignment with Medsafe, HDEC, WHO, and International Committee of Medical Journal Editors (ICMJE) requirements for trial registration and result disclosure.
Scope
This SOP applies to all clinical trials conducted in New Zealand requiring ANZCTR registration. It covers initial registration, registry updates, posting of summary results, and management of registry-related communications. It applies to sponsors, investigators, CROs, regulatory affairs staff, and QA teams.
Responsibilities
- Sponsor: Ensures timely registration of all trials in ANZCTR before first participant enrollment, maintains updates, and discloses results.
- Principal Investigator (PI): Provides accurate trial data for registry submission and reviews registry entries for accuracy.
- Regulatory Affairs (RA): Manages registry submissions, updates, and correspondence with ANZCTR.
- CRO: Supports sponsor in registry management activities as per contractual agreement.
- Quality Assurance (QA): Audits registry records for compliance with SOP and regulatory requirements.
Accountability
The sponsor’s Head of Regulatory Affairs is accountable for compliance with ANZCTR registration requirements. The PI is accountable for ensuring site-level accuracy of trial information submitted to the registry.
Procedure
1. Initial Registration
- Register the trial in ANZCTR prior to enrollment of the first participant.
- Include all required information: protocol title, objectives, eligibility criteria, intervention details, and outcome measures.
- Retain a copy of the registry confirmation in the TMF and ISF.
2. Updates to Registry Records
- Update registry records within 15 working days of protocol amendments.
- Maintain Registry Update Log (Annexure-1).
3. Results Disclosure
- Submit summary results to ANZCTR within 12 months of trial completion.
- Ensure consistency with final study report and regulatory submissions.
4. Ethics and Regulatory Coordination
- Provide registry details in HDEC submissions.
- Ensure Medsafe acknowledges trial registration for regulatory acceptance.
5. Auditing and Archiving
- QA team audits registry entries annually for accuracy.
- Archive all registry-related documents for minimum of 10 years.
Abbreviations
- ANZCTR: Australia New Zealand Clinical Trials Registry
- HDEC: Health and Disability Ethics Committees
- ICMJE: International Committee of Medical Journal Editors
- PI: Principal Investigator
- RA: Regulatory Affairs
- QA: Quality Assurance
- CRO: Contract Research Organization
- TMF: Trial Master File
- ISF: Investigator Site File
Documents
- Registry Update Log (Annexure-1)
- Registry Confirmation Record (Annexure-2)
- Results Disclosure Log (Annexure-3)
References
- Australia New Zealand Clinical Trials Registry (ANZCTR)
- Medsafe — New Zealand Medicines and Medical Devices Safety Authority
- HDEC — Health and Disability Ethics Committees
- ICH E6(R2) Good Clinical Practice
Version: 1.0
Approval
| Prepared By | Checked By | Approved By |
|---|---|---|
| Name: Rajesh Kumar Date: 20/08/2025 Signature: __________ |
Name: Sunita Reddy Date: 22/08/2025 Signature: __________ |
Name: Dr. Meera Iyer Date: 28/08/2025 Signature: __________ |
Annexures
Annexure-1: Registry Update Log
| Date | Protocol No. | Update | Submitted To | Status |
|---|---|---|---|---|
| 10/08/2025 | NZ-2025-04 | Primary endpoint amended | ANZCTR | Approved |
Annexure-2: Registry Confirmation Record
| Registry ID | Protocol No. | Date Registered | Confirmation |
|---|---|---|---|
| ACTRN12625001001 | NZ-2025-04 | 01/08/2025 | Confirmed |
Annexure-3: Results Disclosure Log
| Date | Protocol No. | Results Posted | Status |
|---|---|---|---|
| 20/08/2026 | NZ-2025-04 | Summary results disclosed | Completed |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
|---|---|---|---|---|
| 28/08/2025 | 1.0 | Initial SOP for clinical trial registration and updates in ANZCTR. | New SOP created for compliance with ANZCTR, Medsafe, HDEC, and ICMJE requirements. | Head of Clinical Research |
For more SOPs visit: Pharma SOP.
